Frost & Sullivan announced today that it recognized RapidAI with its 2022 Global Technology Innovation Leadership Award.
RapidAI develops artificial intelligence (AI) algorithms for treating vascular and neurovascular conditions. It offers solutions for stroke diagnosis and triage. Its AI creates high-quality, advanced brain images from non-contrast CT, CT angiography, CT perfusion and MRI diffusion and perfusion studies.
Frost & Sullivan said in a news release that the company “refined its holistic approach to care for life-threatening neurovascular and vascular conditions.” It continues to build a comprehensive software platform aimed to bridge the gaps in care.
The RapidAI platform offers value to a number of hospital environments and applications. Its technology can be used across emergency departments and trauma centers to acute stroke-ready hospitals, primary stroke centers and comprehensive stroke centers.